Login to Your Account



'Adderall' up: Neos gets $18M series C plus $20M loan deal for ADHD push

By Randy Osborne
Staff Writer

Wednesday, April 23, 2014
Neos Therapeutics Inc.'s upsized series C financing – from $15.5 million to $18 million – along with a $20 million loan facility with Hercules Technology Growth Capital Inc. means the firm will "not only have enough money to hit the key regulatory milestones over the next 12-15 months, but to give us financial flexibility into 2016," said Victor Miller, vice president of finance.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription